Wolfram Doehner
#153,702
Most Influential Person Now
Researcher
Wolfram Doehner's AcademicInfluence.com Rankings
Download Badge
Physics
Why Is Wolfram Doehner Influential?
(Suggest an Edit or Addition)Wolfram Doehner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Frailty consensus: a call to action. (2013) (2719)
- Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure (2000) (790)
- Uric Acid and Survival in Chronic Heart Failure: Validation and Application in Metabolic, Functional, and Hemodynamic Staging (2003) (584)
- Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies (2002) (575)
- Nutritional recommendations for the management of sarcopenia. (2010) (564)
- Altered intestinal function in patients with chronic heart failure. (2007) (491)
- Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). (2013) (448)
- The relationship between cholesterol and survival in patients with chronic heart failure. (2003) (411)
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018) (402)
- Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. (2007) (398)
- Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. (2003) (341)
- Sarcopenia: A Time for Action. An SCWD Position Paper (2019) (288)
- Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. (2007) (286)
- Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. (2015) (285)
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (2020) (280)
- Peripheral Chemoreceptor Hypersensitivity: An Ominous Sign in Patients With Chronic Heart Failure (2001) (278)
- Wasting as an independent predictor of mortality in patients with cystic fibrosis (2001) (262)
- Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. (2005) (260)
- Effects of intravenous iron therapy in iron‐deficient patients with systolic heart failure: a meta‐analysis of randomized controlled trials (2016) (258)
- Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management (2017) (245)
- Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2017) (231)
- Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2020) (223)
- Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. (2011) (218)
- Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. (2001) (208)
- Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. (2013) (199)
- Stroke induced Sarcopenia: muscle wasting and disability after stroke. (2013) (195)
- Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. (2012) (189)
- Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. (2012) (187)
- Metabolic impairment in heart failure: the myocardial and systemic perspective. (2014) (184)
- Anemia and inflammation in COPD. (2005) (176)
- Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial (2011) (166)
- Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure: A Double-Blind Placebo-Controlled Crossover Preliminary Study (2010) (156)
- Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. (2014) (153)
- Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. (2014) (150)
- Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. (2007) (150)
- Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure. (2016) (146)
- Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. (2016) (145)
- Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (2011) (140)
- Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. (2019) (134)
- Mid‐regional pro‐adrenomedullin as a novel predictor of mortality in patients with chronic heart failure (2010) (132)
- The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review (2016) (128)
- Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis. (2015) (122)
- Body Weight After Stroke: Lessons From the Obesity Paradox (2011) (118)
- Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2020) (117)
- The obesity paradox in chronic disease: facts and numbers (2012) (114)
- Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association (2018) (112)
- Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) (2018) (111)
- Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. (2001) (110)
- The obesity paradox: weighing the benefit. (2010) (109)
- Stroke-related sarcopenia: specific characteristics. (2015) (107)
- Heart Failure Association of the European Society of Cardiology position paper on frailty in patients with heart failure (2019) (106)
- Muscle wasting in heart failure: An overview. (2013) (106)
- The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure. (2016) (99)
- Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction (2020) (98)
- Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement. (2007) (98)
- Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. (2009) (96)
- Sarcopenia in stroke—facts and numbers on muscle loss accounting for disability after stroke (2011) (93)
- Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer. (2014) (93)
- Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. (2004) (90)
- Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. (2007) (89)
- Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart FailureCLINICAL PERSPECTIVE (2010) (89)
- Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance. (2001) (88)
- Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. (2002) (87)
- Systolic heart failure. (2010) (86)
- Request for regulatory guidance for cancer cachexia intervention trials (2015) (85)
- High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. (2001) (85)
- Metabolically Healthy Obesity and Risk of Mortality:DoestheDefinitionofMetabolic Health Matter? Diabetes Care (2014) (84)
- Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. (2011) (84)
- Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) (2010) (83)
- Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice (2018) (82)
- Stroke–heart syndrome: clinical presentation and underlying mechanisms (2018) (78)
- Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. (2002) (76)
- Dysfunction of respiratory muscles in critically ill patients on the intensive care unit (2016) (76)
- Absolute and functional iron deficiency in professional athletes during training and recovery. (2012) (76)
- Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. (2002) (73)
- Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016. (2017) (70)
- Catabolic Signaling and Muscle Wasting After Acute Ischemic Stroke in Mice: Indication for a Stroke-Specific Sarcopenia (2014) (68)
- Cardiac muscle wasting in individuals with cancer cachexia (2017) (67)
- Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME (2018) (67)
- Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications. (2016) (64)
- Correction to: Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial. (2021) (64)
- Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure? (2005) (63)
- The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure. (2010) (62)
- Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life (2018) (61)
- Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies (2014) (61)
- Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. (2012) (60)
- Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis. (2014) (59)
- Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference (2010) (59)
- Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. (2007) (58)
- Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction (2021) (57)
- The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats (2013) (56)
- Frailty and heart disease. (2013) (55)
- Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. (2010) (55)
- Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia (2012) (55)
- Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease. (2012) (55)
- Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) (2017) (55)
- Chronic heart failure in the very elderly: clinical status, survival, and prognostic factors in 188 patients more than 70 years old. (2001) (54)
- Mechanism and novel therapeutic approaches to wasting in chronic disease. (2013) (54)
- Sarcopenia and Endothelial Function in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF). (2017) (54)
- Detection of muscle wasting in patients with chronic heart failure using C‐terminal agrin fragment: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) (2015) (53)
- Iron Status and Survival in Diabetic Patients With Coronary Artery Disease (2013) (53)
- Cardiac cachexia in early literature: a review of research prior to Medline. (2002) (52)
- Expert opinion paper on atrial fibrillation detection after ischemic stroke (2018) (52)
- Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation (2016) (52)
- Improving exercise capacity and quality of life using non‐invasive heart failure treatments: evidence from clinical trials (2020) (52)
- Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins (2005) (52)
- Anaemia is an independent predictor of death in patients hospitalized for acute heart failure (2010) (51)
- TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy. (2013) (50)
- Nutrition in heart failure: an update (2009) (50)
- The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure (2009) (50)
- Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial (2020) (50)
- The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2011) (49)
- IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia (2011) (48)
- Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. (2004) (48)
- Evaluation of C‐terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation (2015) (47)
- Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2021) (47)
- Uric acid in chronic heart failure. (2005) (47)
- Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. (2013) (46)
- Endothelial Dysfunction of the Peripheral Vascular Bed in the Acute Phase after Ischemic Stroke (2011) (45)
- The Influence of Recovery and Training Phases on Body Composition, Peripheral Vascular Function and Immune System of Professional Soccer Players (2009) (45)
- Increased catabolic activity in adipose tissue of patients with chronic heart failure (2013) (44)
- Muscle wasting as an independent predictor of survival in patients with chronic heart failure (2020) (44)
- Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study (2012) (44)
- Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm'. (2015) (43)
- Overweight, obesity, and all-cause mortality. (2013) (43)
- Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) (2022) (42)
- Iron deficiency in chronic heart failure: case‐based practical guidance (2018) (41)
- Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1 (2011) (41)
- Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke. (2019) (41)
- Iron deficiency in chronic heart failure: case‐based practical guidance (2018) (41)
- Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from Studies Investigating Co-morbidities Aggravating Heart Failure (2016) (40)
- Cardiac cachexia is associated with right ventricular failure and liver dysfunction. (2013) (39)
- Uric acid and survival in chronic heart failure (2004) (39)
- Liver dysfunction and its nutritional implications in heart failure. (2013) (39)
- The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy. (2013) (39)
- Searching for a relevant definition of sarcopenia: results from the cross‐sectional EPIDOS study (2015) (38)
- The cardiac component of cardiac cachexia. (2002) (38)
- Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke. (2012) (38)
- Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome (2020) (38)
- Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure (2009) (37)
- Exercise capacity and body composition in living-donor renal transplant recipients over time. (2009) (37)
- Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction (2015) (36)
- Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation (2010) (36)
- Bone marrow iron depletion is common in patients with coronary artery disease. (2015) (36)
- Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension. (2010) (36)
- Elevated Levels of Asymmetric Dimethylarginine in Chronic Heart Failure: A Pathophysiologic Link Between Oxygen Radical Load and Impaired Vasodilator Capacity and the Therapeutic Effect of Allopurinol (2010) (34)
- Cellular endotoxin desensitization in patients with severe chronic heart failure (2005) (33)
- Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. (2004) (33)
- Impaired Insulin Sensitivity as an Underlying Mechanism Linking Hepatitis C and Posttransplant Diabetes Mellitus in Kidney Recipients (2009) (32)
- Polypill Strategy in Secondary Cardiovascular Prevention. (2022) (31)
- Hormonal consequences and prognosis of chronic heart failure (2011) (31)
- Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease. (2011) (30)
- Cachexia as a common characteristic in multiple chronic disease (2018) (29)
- Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany (2017) (29)
- Models of sarcopenia: Short review. (2017) (29)
- Cachexia in heart disease: highlights from the ESC 2010 (2011) (29)
- Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure (2015) (29)
- Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF). (2013) (28)
- Uric acid as a prognostic marker in acute heart failure — new expectations from an old molecule (2007) (27)
- Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta‐analysis (2019) (27)
- Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia. (2013) (27)
- Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review (2009) (27)
- Body weight changes and incidence of cachexia after stroke (2018) (26)
- Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS) (2013) (26)
- Heart-brain Interactions in Heart Failure. (2018) (26)
- Febuxostat improves outcome in a rat model of cancer cachexia (2015) (26)
- Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial (2013) (26)
- Anaemia in chronic heart failure The relationship to inflammatory cytokine expression and prognostic importance (2002) (25)
- Ursodeoxycholic acid treatment in a rat model of cancer cachexia (2011) (25)
- Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). (2016) (24)
- The importance of return to work: How to achieve optimal reintegration in ACS patients (2019) (23)
- Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference (2012) (23)
- Critical appraisal of the obesity paradox in cardiovascular disease: How to manage patients with overweight in heart failure? (2014) (23)
- Uric acid in CHF: marker or player in a metabolic disease? (2007) (22)
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. (2016) (22)
- The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke (2018) (22)
- Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results. (2017) (22)
- Prognostic performance of serial in‐hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study (2018) (22)
- [Extensive injury of the hemispheric white matter after closed brain trauma with apallic syndrome and partial late rehabilitation]. (1961) (22)
- Adiponectin resistance in heart failure and the emerging pattern of metabolic failure in chronic heart failure. (2010) (21)
- The small intestine: a critical linkage in pathophysiology of cardiac cachexia. (2011) (21)
- Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain (2013) (21)
- Revisiting the obesity paradox in heart failure: new insights? (2011) (21)
- Obesity and the heart a weighty issue. (2006) (20)
- Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure. (2014) (20)
- Ischemic stroke and heart failure: facts and numbers (2015) (20)
- Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable (2019) (20)
- Echocardiographic determinants of mortality in patients >67 years of age with chronic heart failure. (2000) (20)
- High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke (2018) (19)
- Metabolic disturbances in chronic heart failure: A case for the “macho” approach with testosterone?! (2007) (19)
- Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS (2021) (19)
- Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia. (2014) (18)
- Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model. (2013) (18)
- Heart failure therapy: testosterone replacement and its implications. (2006) (17)
- Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters. (2012) (17)
- The relationship between age and production of tumour necrosis factor-α in healthy volunteers and patients with chronic heart failure (2003) (17)
- Uric acid in chronic heart failure—current pathophysiological concepts * (2008) (17)
- Defects in insulin action in chronic heart failure (2000) (17)
- Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure. (2016) (17)
- Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure (2015) (16)
- Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table (2019) (16)
- Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era (2020) (15)
- Sleep‐Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction (2017) (15)
- Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure? (2016) (15)
- Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
- Effects of Dialysis Modality on Blood Loss, Bleeding Complications and Transfusion Requirements in Critically Ill Patients with Dialysis-Dependent Acute Renal Failure (2015) (14)
- The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE‐CRT Study (2020) (14)
- Dementia and the heart failure patient (2019) (14)
- Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. (2005) (14)
- Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure. (2011) (14)
- Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis (2020) (14)
- Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study. (2012) (14)
- Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study) (2016) (13)
- Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial (2022) (13)
- Insulin resistance in chronic heart failure. (2008) (13)
- Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure (2015) (13)
- Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure. (2005) (13)
- Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure (2017) (12)
- Furosemide induces mortality in a rat model of chronic heart failure. (2012) (12)
- Diagnostic biomarkers in cardiovascular disease: the proteomics approach. (2012) (12)
- Original articles 746 Wasting as an independent predictor of mortality in patients with cystic fibrosis R Sharma (2001) (12)
- Abstracts of the 7th Cachexia Conference, Kobe/Osaka, Japan, December 9–11, 2013 (Part 2) (2014) (11)
- Chronic Kidney Disease and Cerebrovascular Disease (2021) (11)
- Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions with the support of the European Board of Neuroin (2021) (11)
- Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke - a retrospective analysis (2015) (11)
- Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure. (2015) (11)
- Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease. (2012) (11)
- Anemia in chronic heart failure--frequency and prognostic impact. (2003) (11)
- Meeting report from the 74th annual scientific sessions of the American Heart Association (AHA). Anaheim, CA, USA, November 11-14, 2001. (2002) (11)
- 280 Body composition and prognosis in 511 chronic heart failure patients: results from three European centers (2004) (11)
- Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study (2013) (10)
- Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest. (2016) (10)
- Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour (2013) (10)
- The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure. (2016) (9)
- Prognostic Value of Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure (CHF) (2008) (9)
- [Anemia and iron deficiency in the elderly. Prevalence, diagnostics and new therapeutic options]. (2012) (9)
- [Iron Deficiency in Chronic Heart Failure: Diagnostic Algorithm and Present-Day Therapeutic Options]. (2017) (8)
- A tissue‐specific screen of ceramide expression in aged mice identifies ceramide synthase‐1 and ceramide synthase‐5 as potential regulators of fiber size and strength in skeletal muscle (2019) (8)
- Abnormal serum calcium levels are associated with clinical response to maximization of heart failure therapy. (2015) (8)
- The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure. (2003) (8)
- Severe Weight Loss and Its Association with Fatigue in Old Patients at Discharge from a Geriatric Hospital (2019) (7)
- The significance of leptin in human--do we know it yet? (2000) (7)
- Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance (2014) (7)
- Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly? (2013) (7)
- Searching for Atrial Fibrillation Poststroke (2019) (7)
- Elevated plasma xanthine oxidase activity in chronic heart failure: Source of increased oxygen radical load and effect of allopurinol in a placebo controlled, double blinded treatment study (2003) (7)
- Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly. (2012) (7)
- Early rehabilitation after stroke: relationship between the heart rate variability and functional outcome (2020) (7)
- Beta blockers and glucose metabolism in chronic heart failure: Friend or foe? (2008) (7)
- Predictors of Anaemia-Development in Patients with Chronic Heart Failure: Results from the Studies Investigating Co-Morbidities Aggravating Heart Failure (SICA-HF) (2014) (7)
- Anaemia predicts health related quality of life in heart failure patients. (2013) (7)
- Andropausal syndrome in men with systolic heart failure. (2013) (6)
- Anemia in chronic heart failure--clinical and prognostic significance. (2005) (6)
- Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy. (2014) (6)
- The importance of rehabilitation in the secondary prevention of cardiovascular disease (2018) (6)
- Expert opinion paper on cardiac imaging after ischemic stroke (2021) (6)
- Transgenerational transmission of an anticholinergic endophenotype with memory dysfunction (2017) (6)
- Ischemic Stroke and Heart Failure: Facts and Numbers. An Update (2021) (6)
- Do we need a reference standard for the muscle mass measurements? (2018) (6)
- Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. (2019) (6)
- Basic research The relationship between high-density lipoprotein, bacterial lipopolysaccharide, and tumour necrosis factor-α in patients with acute decompensated heart failure (2009) (6)
- URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL (2012) (6)
- Late‐onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long‐term survival (2014) (5)
- Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry (2021) (5)
- Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment. (2020) (5)
- ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients (2022) (5)
- Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study. (2017) (5)
- Anemia and inflammation in chronic heart failure (2003) (5)
- Overview of emerging pharmacotherapy in chronic heart failure (2009) (5)
- Sunday, 26 August 2012 (2012) (5)
- Insulin-mediated glucose uptake in congestive heart failure. (2000) (5)
- Weight change with beta-blocker use: a side effect put into perspective. (2008) (5)
- I. Peripheral endothelial dysfunction after subarachnoid haemorrhage: what the fingertips can tell us. (2014) (5)
- Iron deficiency is related to low functional outcome in patients at early rehabilitation after acute stroke (2022) (5)
- Obesity and long‐term outcomes after incident stroke: a prospective population‐based cohort study (2021) (5)
- The Obesity Paradigm and Lifetime Risk of Cardiovascular Disease. (2018) (5)
- C-terminal agrin-fragment as a novel diagnostic marker for muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (2013) (5)
- RNAs in Brain and Heart Diseases † (2020) (4)
- Changes in metabolic and cytokine kinetics during strenuous exercise in patients with chronic heart failure (2000) (4)
- EFFECTS OF INTRAVENOUS IRON THERAPY IN IRON DEFICIENT PATIENTS WITH SYSTOLIC HEART FAILURE: META-ANALYSIS OF RANDOMIZED CONTROL TRIALS (2015) (4)
- Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study (2016) (4)
- The Xanthine Oxidase Inhibitors Oxypurinol and Allopurinol Reduce Wasting and Improve Cardiac Function in Experimental Cancer Cachexia (2009) (4)
- A direct link between haemodynamic failure and inflammatory activation in heart failure: the simplified approach to heart failure and to creation of life. (2014) (4)
- How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology (EAPC). (2022) (4)
- Valvular atrial fibrillation and a CHA2DS2-VASc score of 1-a statement of the ESC working group on cardiovascular pharmacotherapy and ESC council on stroke. (2021) (4)
- Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study (2021) (3)
- Xanthine Oxidase Inhibitors and Insulin Sensitizers (2005) (3)
- The relationship between high-density lipoprotein, bacterial lipopolysaccharide, and tumour necrosis factor-α in patients with acute decompensated heart failure (2009) (3)
- Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke (2022) (3)
- Monday, 27 August 2012 (2012) (3)
- The role of cardiologists on the stroke unit (2020) (3)
- Inflammatory in Hear t Failure Revisited: Much More than Innocent Bystanders (2009) (3)
- Insulin-like growth factor-I can be helpful towards end of life (2001) (3)
- Estimating fat mass in heart failure patients (2016) (3)
- Invited commentary Uric acid in chronic heart failure: marker or therapeutic target? Commentary on: Pawan D. Patel, Rohit R. Arora. Uric acid and xanthine oxidase: perspectives in chronic heart failure (Arch Med Sci 2008; 4, 3: 219–225) (2008) (3)
- Validation of the FEW16 questionnaire for the assessment of physical well‐being in patients with heart failure with reduced ejection fraction: results from the CIBIS‐ELD study (2015) (3)
- The Prevalence of Iron Deficiency in Patients with Heart Failure with Preserved Ejection Fraction and its Association with Elevated Pulmonary Pressure, Reduced Exercise Capacity and Quality of Life (2015) (3)
- [Diagnostic and treatment principles of iron deficiency anaemia]. (2015) (3)
- Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR‐Reduced (2022) (3)
- Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How? (2022) (3)
- Intravenous iron supplementation is state of the art therapy in patients with heart failure and iron deficiency (2019) (2)
- Cytoprotection in acute myocardial infarction. (1999) (2)
- The evolving obesity paradigm story: from heart failure to atrial fibrillation. (2019) (2)
- Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial. (2022) (2)
- Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls. (2020) (2)
- Letter by Doehner et al regarding article, "Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox". (2011) (2)
- Differentiating between body fat and lean mass—how should we measure obesity? (2008) (2)
- The impact of obesity on survival in chronic heart failure patients (2000) (2)
- How to determine a metabolically healthy body composition in cardiovascular disease. (2014) (2)
- Relevance of Heart Failure in Prevention, Treatment and Prognosis of Ischemic Stroke (2017) (2)
- Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research (2010) (2)
- Comorbidities of chronic heart failure - a systemic syndrome requiring cross-specialty efforts. (2018) (2)
- Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency (2022) (2)
- Alterations in Nutrition and Body Mass in Heart Failure (2011) (2)
- Chronic Heart Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence, Clinical Characteristics, Treatment and Mortality (2009) (2)
- World Congress of Cardiology 2006. Barcelona, Spain, September 2-5, 2006. (2007) (2)
- Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies (2020) (2)
- Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation? Reply (2018) (2)
- Comment on Hinnouho et al. Metabolically Healthy Obesity and Risk of Mortality: Does the Definition of Metabolic Health Matter? Diabetes Care 2013;36:2294–2300 (2014) (2)
- Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke (2022) (2)
- Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials (2022) (2)
- 3528 POSTER Fatigue in pancreatic cancer: the potential link between exertional dyspnea, exercise limitation, skeletal musculature and neurohormonal activation (2007) (2)
- The roles of immunity and autoimmunity in chronic heart failure. (2006) (2)
- Questions in cardiac resynchronization therapy: metabolic implications. (2006) (1)
- Prevalence and clinical implications of liver dysfunction in chronic heart failure (2013) (1)
- Pulmonary Function During Beta-blocker Titration In Elderly Patients With Heart Failure: The CIBIS-ELD Analysis (2010) (1)
- Abstracts of the 10th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Rome, Italy, 8‐10 December 2017 (Part 2) (2018) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey. (2021) (1)
- Comment on ‘Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes’ by Niedziela et al. (2020) (1)
- Importance of selenium status in patients with chronic heart failure (2015) (1)
- Heart Failure as a Risk Factor for Stroke (2017) (1)
- Intestinal permeability, bowel wall thickness and bacterial biofilm in patients with chronic heart failure compared to healthy controls (2006) (1)
- PRESTO (a mammoth trial that could have been prevented), HPS and REMATCH. (2002) (1)
- Stroke patients need cardiologists. (2020) (1)
- Erratum to: Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference (2012) (1)
- Abstract 5902: Upregulation Of Stat-3, Socs-1, Pro-inflammatory And Antiinflammatory Circulating Cytokine mRNA Gene Expression In CHF Patients With And Without Cachexia Compared To Healthy Control Subjects (2008) (1)
- Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry (2021) (1)
- Heart–brain interactions in patients with heart failure, including takotsubo syndrome: a need to monitor autonomic sympathetic activity: reply (2018) (1)
- Lean tissue-adjusted versus body weight-adjusted peak oxygen consumption and mortality prediction in chronic heart failure (2002) (1)
- Cardiac Cachexia in Chronic Heart Failure: The Metabolic Facet of CHF (2010) (1)
- Lean ∆issue-∞djusted Peak Oxygen Consumption in Chronic Heart Failure Patients (2003) (1)
- Cytoprotection in acute myocardial (1999) (1)
- Uric acid in chronic heart failure: marker or therapeutic (2008) (1)
- ANAEMIA AND SURVIVAL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009) (1)
- Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) – Study protocol for a prospective observational study (2019) (1)
- Vascular effect of insulin in endothelial dysfunction. (2001) (1)
- Insulin-mediated glucose uptake in congestive heart failure. (1999) (1)
- Comment on: “Handgrip weakness, low fat‐free mass, and overall survival in nonsmall cell lung cancer treated with curative‐intent radiotherapy" by Burtin et al. (2020) (1)
- TNF-alpha system in CHF. (2000) (1)
- Body composition in patients with diastolic dysfunction and heart failure with preserved ejection fraction and its effect on muscle strength and exercise capacity (2013) (1)
- 842-4 Deranged steroid metabolism independently predicts anemia in chronic heart failure (2004) (1)
- Diet and nutritional aspects of cardiac rehabilitation (2020) (1)
- The obesity paradigm in cardiovascular disease: the need for differentiated weight management. (2020) (1)
- Similar Patterns of Autonomic Dysfunction and Exercise Capacity in Patients with Chronic Heart Failure and Lung Cancer (2009) (0)
- The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia. (2023) (0)
- 364 Risk stratification of patients with chronic heart failure based on metabolic functional and haemodynamic parameters (2008) (0)
- Patients With Stable Chronic Heart Failure Impaired Insulin Sensitivity as an Independent Risk Factor for Mortality in (2011) (0)
- Interdisciplinary stroke care in 2020: the need for cardiologists to learn about stroke (2020) (0)
- P4632Impact of body mass index on hospital mortality in acute myocardial infarction over 15 years: Findings from 27,607 patients of a local myocardial infarction registry (2017) (0)
- Response to Letter Regarding Article, “Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure: A Double-Blind Placebo-Controlled Cross-Over Preliminary Study” (2010) (0)
- P4386Sleep disordered breathing (SDB) increases the risk of heart failure decompensation: clinical factors and bioelectrical impedance analysis (2017) (0)
- 1929 Insulin resistance predicts impaired survival in chronic heart failure (2003) (0)
- Smoking and Other Risk Factors in Type 2 Diabetes. (2018) (0)
- Muscle Wasting in Patients with Heart Failure with Preserved Ejection Fraction and Its Impact on Muscle Strength and Functional Capacity during Exercise (2014) (0)
- 1069-117 Prognostic impact of catabolic/anabolic imbalance in chronic heart failure (2004) (0)
- A Weighty Issue (2006) (0)
- Dynamics of the left ventricular mass in heart failure patients with and without cachexia: a prospective cardiovascular magnetic resonance study (2002) (0)
- Smoking and Other Risk Factors in Type 2 Diabetes. (2018) (0)
- [THE SOCIOLOGICAL ROLE AND SOCIAL PROBLEMS OF THE PSYCHIATRIC HOSPITAL]. (1965) (0)
- Sa1781 Chronic Heart Failure Is Associated With Bowel Wall Edema, Reduced Intestinal Blood Flow, Gastrointestinal Symptoms and Bacterial Growth (2015) (0)
- Cardiac Thrombogenicity in Stroke: Mechanisms and Evaluation. (2022) (0)
- 503 Uric acid and immune activation in patients with chronic heart failure (2004) (0)
- 642 Mid-regional pro-atrial natriuretic peptide (MR-proANP) better than N-terminal Pro B-type natriuretic peptide (NT-proBNP) predicts survival in patients with chronic heart failure (CHF) (2006) (0)
- [Concurrence of commotio cerebri and cervico-encephalic syndromes]. (1961) (0)
- Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 ESC heart failure guidelines into clinical practice: (2018) (0)
- The impact of body weight on mortality after stroke: the controversy continues. (2015) (0)
- Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival: Late-onset hypogonadism in heart failure (2014) (0)
- SGLT2 inhibitor treatment lowers serum uric acid in patients with HFrEF - Lessons from clinical trials. (2022) (0)
- Abstract 2969: Altered Intestinal Barrier Function and Immune Activation in Patients with Chronic Heart Failure Compared to Controls (2006) (0)
- 257 Mid‐regional pro‐adrenomedullin as a novel and prognostic marker in chronic heart failure (CHF) (2006) (0)
- Survival and body fat in hemodialysis patients: true association or effects of concomitant therapy? (2006) (0)
- Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) (2022) (0)
- Magnetic resonance imaging of organ iron before and after correction of iron deficiency in patients with heart failure. (2023) (0)
- Abstracts: Cardiac resynchronisation therapy: results and mechanisms (2009) (0)
- Mental involvement in heart failure. (2021) (0)
- Serum uric acid (UA) in cachectic and non-cachectic chronic heart failure (CHF) patients – Relation to peripheral vascular resistance (PVR) (2000) (0)
- [Iron deficiency in heart failure. A new diagnostic therapy algorithm - evidence-tested and workable]. (2018) (0)
- Insulin sensitivity, but not hyperglycemia, may be superior as a prognostic marker and therapeutic target for diabetes in heart failure. (2012) (0)
- When a reference value makes all the difference (2012) (0)
- 370 Catabolic/anabolic steroid imbalance predicts survival in chronic heart failure (2004) (0)
- Cytokines and cytokine receptors are predictive for increased mortality in chronic heart failure (2000) (0)
- Losartan: the dose does it (2010) (0)
- Metabolic studies in chronic heart failure. (2004) (0)
- Abstract 3749: Plasma Asymmetric Dimethylarginine (ADMA) is Elevated in CHF: Endogenous NO-Inhibition Relates to Clinical Status and to Impaired Vasodilator Capacity. (2006) (0)
- [Comments on the 2014 guidelines of the ESC/ESA: recommendations for the pre-operative assessment in non-cardiac surgery]. (2015) (0)
- Mental involvement in heart failure. (2021) (0)
- Wasting of the left ventricle in patients with cardiac cachexia: A prospective cardiovascular magnetic resonance study (2001) (0)
- Abstract 813: Liver Function Markers and Mortality in Patients with Chronic Heart Failure (2008) (0)
- Abstract 13341: Beneficial Effects of Beta Blockers in Elderly Patients with Chronic Heart Failure Are Not Influenced by Cardiac Rhythm -- Insight From the Cardiac Insufficiency Bisoprolol Study in Elderly (2010) (0)
- Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS (2021) (0)
- Comment on: “Experimental ischaemic stroke induces transient cardiac athrophy” by Veltkamp et al. (2020) (0)
- Insulin resistance and survival in chronic heart failure (2003) (0)
- Plasma bioactive adrenomedullin predicts outcome after acute stroke in early rehabilitation (2023) (0)
- Metabolic regulation of adrenomedullin, a novel marker of metabolic syndrome and type 2 diabetes, in subjects with different stages of glucose tolerance (2013) (0)
- [PREMATURE AGING FROM THE VIEWPOINT OF THE NEUROLOGIST]. (1964) (0)
- Historic Views on Cachexia in Humans with Special Reference to Cardiac Cachexia (2006) (0)
- [On the therapy of paranoid hallucinatory syndrome by a new neuroleptic mixture]. (1963) (0)
- Lipopolysaccharide Responsiveness is an Independent Predictor of Death in Chronic Heart Failure (2012) (0)
- Anaemia in Patients Hospitalized for Acute Heart Failure (2009) (0)
- The European Society of Cardiology XXIV Annual Congress 2002. Berlin, Germany, 31 August-4 September, 2002. (2003) (0)
- Abstract 20230: Prognostic Value of Low Spot Urine Creatinine is Independent of Lean Body Mass in Patients With Heart Failure (2017) (0)
- Response to the letter to the editor from Xue and Varadhan titled "What is missing in the validation of frailty instruments?". (2014) (0)
- Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction—A Pilot Study (2022) (0)
- Overweight, Obesity, and All-cause Mortality Downloaded From: Http://jama.jamanetwork.com/ by a National Institutes of Health User on 04/23/2013 (2013) (0)
- Exercise limitation in pancreatic cancer: the potential impact of changes in body composition (cachexia) (2006) (0)
- The in fl uence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure (2016) (0)
- Symptoms associated with male aging in men with systolic heart failure (2013) (0)
- Hemoglobin independently predicts exercise capacity in anemic patients with chronic heart failure (2003) (0)
- Proenkephalin A as Potential Prognostic Biomarker in Acute Ischemic Stroke (2020) (0)
- Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials. Letter regarding the article ‘Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF (2022) (0)
- The Relationship between Serum Lipids and Survival in Patients Hospitalized With Heart Failure (2010) (0)
- Iconography : Echocardiographic determinants of mortality in patients >67 years of age with chronic heart failure (2011) (0)
- Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure. (2023) (0)
- Beware of TOSCA's kiss or metabolic and hormonal aspects of heart failure. (2021) (0)
- Award winning ceremony: best paper prize and student awards 2015/2016. ICE Kraków Congress Centre, Kraków, Poland. (2016) (0)
- The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies. (2023) (0)
- Overviewofemerging pharmacotherapyinchronic heartfailure (2009) (0)
- TISSUE CELL INTEGRITY IS AN IMPORTANT DETERMINANT TO PREDICT MUSCLE STRENGTH IN PATIENT IN POST STROKE REHABILITATION (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Wolfram Doehner?
Wolfram Doehner is affiliated with the following schools:
